Therapies

IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator

8 monthes ago   |   By Xconomy

IFM Therapeutics has raised $55.5 million to launch its third drug subsidiary as well as an incubator, both of which are focused on developing new therapies for inflammatory diseases and cancers. Those endeavors will be led by a familiar face. Boston-based IFM has promoted its vice president of research and development, Martin Seidel, to become its CEO and a member of the board of directors. Gary Glick, IFM's co-founder and CEO since its formation two years ago , is taking on a new role as executive chairman of the board. IFM Therapeutics operates a business structure that houses its...
Read more ...

 


Search by Tags

   Therapies      Drugs      Discovery      Cancer      Therapeutics      Drug      Research      Boston      Boston blog main      Boston top stories      National blog main      National top stories      New York blog main      New York top stories      Abingworth      Atlas Venture      Autoimmune Diseases      Biotech      Cancer      Deals      Gary Glick      IFM Therapeutics      Inflammatory Diseases      Investing      Life Sciences      Martin Seidel      Novartis      Omega Funds      Startups      Venture Capital  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Pfizer's Bourla: There's Coronavirus Vaccine Pressure, But It's Not Political

Pfizer's Bourla: There's Coronavirus Vaccine Pressure, But It's Not Political

Pfizer Inc. CEO Albert Bourla said he doesn't worry about political pressure to bring potentially the first coronavirus vaccine to market, but can't escape feeling the weight... Read more ...

Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup

Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup

Ligand Pharmaceuticals plans to acquire recombinant protein therapeutics maker Pfenex for $438 million, the companies announced Monday. The larger company agreed to pay $12 per... Read more ...

Bayer Boosts Women's Health Drug Pipeline, Paying $425M for KaNDy

Bayer Boosts Women's Health Drug Pipeline, Paying $425M for KaNDy

Bayer has been building up its women's health drug pipeline by striking deals and on Tuesday the pharmaceutical giant unveiled its latest one : $425 million up front for KaNDy... Read more ...

In precisionFDA Challenge, PacBio HiFi Reads Outperform Both Short Reads and...

In precisionFDA Challenge, PacBio HiFi Reads Outperform Both Short Reads and Noisy Long Reads

Figure 1. PrecisionFDA Truth Challenge V2 Results. Of the single-technology entries, those that use PacBio HiFi reads delivered the highest accuracy in all categories... Read more ...

Keeping Cool Efficiently During Heat Waves

Keeping Cool Efficiently During Heat Waves

Berkeley Lab scientist Iain Walker Heat waves are becoming a more regular occurrence across the country. Iain Walker , Leader of the Residential Building Systems Group at... Read more ...

Roche Gut Disease Drug Produces Mixed Results in Late-Stage Trials

Roche Gut Disease Drug Produces Mixed Results in Late-Stage Trials

Results from four studies within a major Roche-run clinical trials program of an investigational gut disease drug have muddled the antibody's path forward after its performance... Read more ...

International Physicists Join Forces in Hunt for Sterile Neutrinos

International Physicists Join Forces in Hunt for Sterile Neutrinos

These four Daya Bay detectors are submerged in a pool of ultrapure water that helps to shield against naturally occurring radiation. Note: This press release is adapted from... Read more ...

Selfish genes take sides in the battle of the sexes

Men may have a surprising genetic advantage over women, according to new research carried out at the University of St Andrews. Read more ...

Part-Time Logistics Coordinator

Job Duties Logistics: -Will require basic lab work such as: aliquoting, dilutions, and lyophilizing -Help set up and pack shipping boxes daily, generating shipping labels... Read more ...

'AeroNabs' promise powerful, inhalable protection against COVID-19

Scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes COVID-19. The researchers engineered a completely synthetic... Read more ...